BlackRock Global Funds - World Healthscience Fund D5 GBP Inc
Category Sector Equity Healthcare
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
£14.70
£0.10 (+0.68%)
Fund Code
BGWDI
BK6KTX9
LU2112292763
Prices updated as at 15 May 2024
Prices in GBP
Investment objective
The Fund seeks to maximise total return and invest in a manner consistent with the principles of environmental, social and governance (“ESG”) investing. The Fund invests globally at least 70% of its total assets in the equity securities of companies whose predominant economic activity is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology. Currency exposure is flexibly managed.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
| Fund status | Open |
| Fund type | SICAV |
| Fund manager | Xiang Liu, Erin Xie |
| 14.7 | |
| 12.61 | |
| Fund comparative index | MSCI World/Health Care NR USD |
| - | |
| - | |
| 1.06 | |
| 0.33 | |
| 0.00 | |
| Sector Equity Healthcare | |
| No | |
| Fund provider | BlackRock (Luxembourg) SA |
| Share class launch date | 26 Feb 2020 |
| £11.03b | |
| - | |
| - | |
| - | |
| Quarterly |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.
